Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Client Messenger now available for ALL eFile submissions
-
We are excited to announce that ALL eFiles submission are now eligible for Client Messenger!
Messenger allows you to receive binding review decisions on pivotal segments of your piece within 1 business day.
To request Client Messenger, select ‘yes’ on the submission form field ‘Request Messenger Fee”. Please note that Messenger can also be requested after initial submission by contacting review@paab.ca.
Want to learn more about Client Messenger and see some examples of when it can be used to help augment the speed of review? Visit our Administrative Guidelines for Client Messenger Use.
We hope to message with you soon!
The PAAB team.